AAW PHARMA LIMITED

🌿Early-stageactive
15033008 · ltd · incorporated 2023-07-27
Investment thesis
Growth-phase business — story-led; valuation sensitive to momentum.
Why interesting: Trading is scaling; acquirers paying for trajectory get disproportionate leverage.
Why risky: Price often leads fundamentals; dependency on founder often high.
🔒Estimated value
Upgrade to see
Turnover
year to Jul 2025
Net worth
£-11.3k
book net assets
Opportunity
70/100
Strong
🔔
Follow this company (free)
Email alerts on filings, charges, director changes, gazette notices. No account needed.

Unsubscribe any time from any email. GDPR-respectful.

What this business does
Primary activity: Dispensing chemist in specialised stores
Sector: Wholesale & retail
Investor take
Pass (distressed without resilience)
Distressed active trading company — structural issues outweigh the discount.

Opportunity 70/100 (strong), bankability 70/100. Share purchase looks the cleaner deal structure. Most likely exit: distressed disposal / insolvency (65/100).

Data confidence

Overall: medium (79/100)

Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.

Company profile
address, 1 SIC codes, incorporation date
100
Financials
2 years of iXBRL accounts extracted (YoY deltas available) + narrative notes parsed
75
Lenders & charges
Confirmed no charges registered
85
Directors & officers
3 officers (3 active, 3 linked, 3 with DOB)
90
Ownership & PSC
3 active PSC(s) of 3 total, 3 with control declared
90
Director network
5 connected companies via shared directors
60
Filing history
5 filings
60
Gazette notices
No matching gazette notices (standard for active companies)
60
Opportunity Score
70/100Strong
PassWatchWorth a lookStrongExceptional 

Solid opportunity signal. Worth a dedicated memo and management meeting.

Business quality
60
Adequate — check latest filings for context.
Acquirability
50
Some acquirability indicators.
Risk profile
85
Few red flags.
Signal strength
90
Good data coverage for analysis.

Signals from accounts

Derived from iXBRL accounts · FRS 102
Negative net assets
Liabilities exceed assets by £11,295
Cash YoY
+75%
Year on year

Key financials

2 years extracted from filed iXBRL accounts
Cash
£36k
↑ 75% YoY
Net Worth
-£11k
↑ 31% YoY
Current Assets
£122k
↑ 30% YoY
Current Liabilities
-£16k£11k£39k£67k£95k£122kJul 2024Jul 2025

Hover to see exact values · click legend to toggle series

Financials

Extracted from Companies House accounts · FRS 102
Metric2025-07-312024-07-31
Total assets£-11.3k£-16.3k
Current assets£122.3k£94.2k
Cash£35.7k£20.4k
Debtors£61.5k£48.8k
Net assets£-11.3k£-16.3k

Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.

🔒Filing-note intelligence

2 signals detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.

Available from the Pro tier upwards.

See pricing →

Recent activity

Last 30 days
1
filing
  • 1 accounts
Last 90 days
1
filing
  • 1 accounts
Last 180 days
1
filing
  • 1 accounts
Counts from Companies House filing history.
Corporate timeline (7 events)Click to expand
  1. 2026-04-30
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  2. 2025-04-26
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  3. 2023-07-27
    🏢
    Company incorporated
    As AAW PHARMA LIMITED
  4. 2023-07-27
    ADREES, Muhammad appointed
    director
  5. 2023-07-27
    BINYAMEEN, Abu-Bakr Shahzada appointed
    director
  6. 2023-07-27
    GUL, Mohammed Wasim appointed
    director
  7. 2023-07-27
    📄
    incorporation-company
    incorporation · NEWINC

Owner dependency

55/100
Moderate — manageable with handover

Some founder dependency, but not acute. A structured handover period should cover most risk.

FACTORS
  • +Young company: Only 2.8 years old — management layer unlikely to be developed.

Succession & seller-readiness

30/100
Weak signal

Limited succession signal. Not a near-term off-market candidate.

Red flags

clean
No red flags detected from available public data. (This is not a clean bill of health — detailed accounts review still recommended.)

Group structure

3 corporate shareholders identified. Group structure is distributed.

🏛️
Pharmacy2me Limited
Corporate parent · holds 25-50% shares · board control
significant stake
🏛️
Ma Uk Pharma Ltd
Corporate parent · holds 25-50% shares · board control
significant stake
🏛️
W G Pharma Care Ltd
Corporate parent · holds 25-50% shares · board control
significant stake
AAW PHARMA LIMITED
This company · 15033008

Parent relationships inferred from Persons with Significant Control filings. Full subsidiary tree requires reverse-lookup (coming).

Shareholders & ownership

3 active beneficial owners
NameSharesVoting rightsNature of controlNotified
Pharmacy2me Limited
Corporate entity
2550%
25–50%board control25-50% shares · 25-50% voting · board control27/07/2023
Ma Uk Pharma Ltd
Corporate entity
2550%
25–50%board control25-50% shares · 25-50% voting · board control27/07/2023
W G Pharma Care Ltd
Corporate entity
2550%
25–50%board control25-50% shares · 25-50% voting · board control27/07/2023

From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.

🔒Co-director network graph

Radial SVG graph showing every company connected via shared directors, colour-coded by status.

Available from the Pro tier upwards.

See pricing →

Similar companies

Active · Retail · WS postcode area
CompanyEst. valueTurnoverNet worthStaffAgeOppDirector
180 DART SHOP LTD
16380118 · est 2025 · no financials extracted
1y
24-SEVEN CONVENIENCE STORES GROUP LTD
15761397 · est 2024 · no financials extracted
1y
3D CREATIVE CRAFTS LTD
16462520 · est 2025 · no financials extracted
3J HERBAL LTD
15742690 · est 2024 · no financials extracted
1y
3RIO FUSION LTD
16214180 · est 2025 · no financials extracted
1y
4514OFFICIAL LTD
15448105 · est 2024 · no financials extracted
2y
A2Z LOCAL LTD
15896997 · est 2024 · no financials extracted
1y
A5 FURNISHINGS LTD
14183615 · est 2022 · no financials extracted
3y
A5 UNIQUE LIMITED
15941460 · est 2024 · no financials extracted
1y
AA DISTRIBUTORS LTD
16565456 · est 2025 · no financials extracted
AAK WM LTD
15167524 · est 2023 · no financials extracted
2y
AAYAN TEXTILES LTD
13877604 · est 2022 · no financials extracted
4y
Peers ranked by estimated value, then turnover, then opportunity score.See all →
🔒Tailored diligence questions

7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.

Available from the Pro tier upwards.

See pricing →
🔒Advanced scoring suite

Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.

Available from the Pro tier upwards.

See pricing →

Company details

Statusactive
Typeltd
Incorporated2023-07-27
Jurisdictionengland-wales
Primary SIC47730 — Dispensing chemist in specialised stores

Registered office

36 Lichfield Street
Walsall
WS1 1TJ
England

Filing status

Accounts
Next due: 2027-04-30
Last made up to: 2025-07-31
Confirmation statement
Next due: 2026-08-09
Last: 2025-07-26

Officers (3 active · 0 resigned)

ADREES, Muhammad
director · ~42y · appointed 2023-07-27
View their other companies + combined net worth →
Active
BINYAMEEN, Abu-Bakr Shahzada
director · ~34y · appointed 2023-07-27
View their other companies + combined net worth →
Active
GUL, Mohammed Wasim
director · ~36y · appointed 2023-07-27
View their other companies + combined net worth →
Active

Click a director name to see their full track record across all companies.

Recent filings (5 total)

accounts-with-accounts-type-total-exemption-full
accounts · AA
2026-04-30
confirmation-statement-with-no-updates
confirmation-statement · CS01
2025-07-28
accounts-with-accounts-type-total-exemption-full
accounts · AA
2025-04-26
confirmation-statement-with-no-updates
confirmation-statement · CS01
2024-07-29
incorporation-company
incorporation · NEWINC
2023-07-27